| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 11/09/2000 | CA2366805A1 Benzimidazolones and analogues and their use as progesterone receptor ligands |
| 11/08/2000 | EP1049684A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| 11/02/2000 | EP0627425B1 3-oxo-1,4-benzothiazine derivative |
| 11/01/2000 | CN1058004C Heterocyclo-benzoylguanidin |
| 10/26/2000 | WO2000063197A1 Hydroxamic acid derivative |
| 10/25/2000 | EP1046627A2 Enantiopure reagents and process for the separation of enantiomers |
| 10/21/2000 | CA2305944A1 Process for separating enantiomers and enantiopur reagent |
| 10/18/2000 | EP1044194A1 Receptor with an affinity for compounds of the oxazoline class |
| 10/17/2000 | US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 10/12/2000 | WO2000059884A1 Pharmaceutically active compounds and methods of use thereof |
| 10/12/2000 | WO2000009106A3 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 10/12/2000 | WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 10/12/2000 | CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 10/12/2000 | CA2361734A1 Pharmaceutically active compounds and methods of use thereof |
| 10/11/2000 | EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 10/11/2000 | CN1057296C Morpholine and thiomorpholine tachykinin receptor antagonists and use |
| 10/10/2000 | US6130214 Benzothiazin and benzoxazin derivatives; their preparation and uses |
| 10/04/2000 | EP1041070A1 Process for preparing cyclic thioamides |
| 09/26/2000 | US6124351 For treatment of cerebrovascular disorders, in particular, occlusive cerebrovascular disorders in which nitrogen oxide or its metabolites would be involved |
| 09/21/2000 | WO2000055147A1 Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use |
| 09/21/2000 | WO2000054759A2 Lxr modulators |
| 09/21/2000 | CA2367595A1 Lxr modulators |
| 09/20/2000 | EP1036821A1 Process for the preparation of thiazine-indigo compounds and of new intermediates therefor |
| 09/19/2000 | US6120696 Proton conductors in liquid form |
| 09/08/2000 | WO2000051992A1 Fused bicyclic oxazinone and thiazinone fungicides |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/05/2000 | US6114392 A norbornane derivatives for reducing the side effect of agmatine, in the treatment of stroke and dementia |
| 08/31/2000 | WO2000050414A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical composition containing them |
| 08/31/2000 | WO2000050380A1 Monoamine reuptake inhibitors for treatment of cns disorders |
| 08/31/2000 | CA2365793A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical composition containing them |
| 08/30/2000 | CN1265096A Hydrazine derivatives |
| 08/29/2000 | US6110872 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 08/17/2000 | WO2000012076A9 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 08/16/2000 | EP1027347A2 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them |
| 08/16/2000 | EP1027055A1 3-carboalkoxy-2,3-dihydro-1h-phenothiazin-4(10h)-one derivatives |
| 08/09/2000 | EP1024810A1 Method for optimizing retinal and optic nerve health |
| 08/08/2000 | CA2097695C Biological stain composition, method of preparation and method of use for delineation of epithelial cancer |
| 08/08/2000 | CA2012137C Dibenzoheterocyclic hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase |
| 08/03/2000 | WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 08/03/2000 | WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 08/03/2000 | CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 08/02/2000 | CN1055085C Sacchrin zinc and its producing process |
| 08/01/2000 | CA2019335C Phenylalkan (en)oic acids |
| 07/26/2000 | EP1021190A1 Novel amide derivatives |
| 07/26/2000 | EP0755458A4 Electrogenerated chemiluminescence labels for analysis and/or referencing |
| 07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | WO2000041685A1 Ccr-3 receptor antagonists |
| 07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/12/2000 | CN1054379C Analgesic compounds and their prepn. and their use |
| 07/11/2000 | US6086852 Conformational isomers of toluidine blue o, and n-demethylation derivatives; synthesis, in which a complexing agent is introduced prior to the last stage of oxidation of a three-step synthesis from n,n-dimethyl-p-phenylenediamine |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/05/2000 | EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 07/05/2000 | EP0734381B1 Morpholine tachykinin receptor antagonists |
| 07/05/2000 | EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 07/04/2000 | US6083651 Phenothiazine or phenoxazine derivative, charge-transporting material comprising the same, and electrophotographic photoreceptor |
| 06/29/2000 | DE19915165A1 Inhibitor composition, useful to inhibit the polymerization of radically polymerizable mixtures comprises a polyvinylimidazole and a phenothiazine |
| 06/28/2000 | CN1053899C Acylguanidine, its preparation process and use, and pharmaceutical composition contg. same |
| 06/21/2000 | EP1009743A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 06/21/2000 | EP1009731A1 Method for producing aryloligoamines |
| 06/14/2000 | EP0777645B1 Oxime ethers and their use as pesticides |
| 06/08/2000 | WO2000032583A1 Antitumor dibenzofluorene derivatives |
| 06/08/2000 | WO2000032175A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 06/08/2000 | CA2352878A1 Antitumor dibenzofluorene derivatives |
| 06/08/2000 | CA2350597A1 Methods and compositions for restoring conformational stability of a protein of the p53 family |
| 06/06/2000 | US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases |
| 05/31/2000 | EP1003491A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases |
| 05/18/2000 | WO2000009479A3 Heterocyclic thioesters or ketones for vision and memory disorders |
| 05/18/2000 | WO2000004892A3 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/17/2000 | EP1000051A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/10/2000 | EP0999208A1 Nitrogenous heterocyclic compounds and hyperlipemia remedy containing the same |
| 05/10/2000 | CN1252799A N-heterocyclic derivatives as NOS inhibitor |
| 05/04/2000 | WO1999062888A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 05/03/2000 | EP0997147A1 Amino acid derivatives |
| 05/03/2000 | EP0996440A1 Method for treatment of glutamate related disorders |
| 04/27/2000 | WO2000023425A1 New compounds, their preparation and use |
| 04/26/2000 | EP0810998B1 Phenyl diketone derivatives as herbicides |
| 04/26/2000 | CN1251523A Sulphonamide derivatives |
| 04/25/2000 | US6054453 Hypolipidemic, antihyperglycemic uses. |
| 04/25/2000 | US6054414 Herbicide |
| 04/19/2000 | EP0993442A1 Hydrazine derivatives |
| 04/19/2000 | EP0666862B1 6-(substituted methylene) penems and intermediates |
| 04/11/2000 | US6048859 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 04/11/2000 | CA1340955C Stilbene derivatives |
| 04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 03/30/2000 | WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/30/2000 | WO2000016603A2 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2344376A1 Bridged heterocyclic derivatives |
| 03/30/2000 | CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/28/2000 | CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 03/23/2000 | DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease |
| 03/22/2000 | EP0986384A1 Inhibitors of protein isoprenyl transferases |
| 03/15/2000 | CN1247531A Arylsulfonyl hydroxamic acid derivatives |
| 03/14/2000 | US6037469 Beta lactamase inhibitor and antibacterial; for treating bacterial infections in humans and animals |
| 03/09/2000 | WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 03/09/2000 | WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 03/09/2000 | CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 03/09/2000 | CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 03/08/2000 | EP0984282A2 Particles having an incorporated composition comprising a chemiluminescent compound |
| 03/08/2000 | EP0984281A2 A homogeneous assay for determining analyte |
| 02/29/2000 | US6030767 Adding dye to whole blood or blood components such as erythrocytes or plasma, then irradiating with light of an appropriate intensity and wavelength for a sufficient time; for deactivating viruses, bacteria, parasites and leukocytes |